Pinned Tweet
I am deeply honored to succeed Dr. Urba & I am committed to building upon his legacy of transformational immuno-oncology research & a world-class cancer center dedicated to translating the next generation of immunotherapies from lab bench to the bedside. @ChilesResearch
Providence is excited to announce Bryan Bell, M.D., as executive medical director of Providence Cancer Institute and director of the Earle A. Chiles Research Institute @ChilesResearch. Walter Urba, M.D., Ph.D., wll retire at the end of the year. blog.providence.org/regional-blog-…
14
4
51
7,812
Great discussions at @BeckersHR’s Oncology Summit in Chicago on 3 critical issues shaping cancer care:
🔬 Precision oncology: Our GigaPath/GigaTIME AI research
🏥 Access = treat access failures as a reportable safety signal
🧬 Sustaining innovation: research as a service line
🔬 Precision oncology: Our GigaPath/GigaTIME AI research
🏥 Access = treat access failures as a reportable safety signal
🧬 Sustaining innovation: research as a service line
0
0
0
165
To celebrate the birthday of William Shakespeare, I’m sharing a few lines from my most favorite sonnet, Sonnet 116. I’ve converted a few of my friends to its cause, and I’m hoping you’re next. Cheers!
You can hear the entire collection in “Patrick Stewart Performs the Complete espeare” available now: bit.ly/PatrickStewart…
@SimonAudio
#NationalShakespeareDay
0
0
0
120
Thanks to Mike Meyer & team for an outstanding #CCX2026! Inspiring discussions with leaders @HutchPresident @CliffordHudis @KimrynRathmell & many others on AI, innovation & cancer outcomes. My takeaway: Measure what matters to patients and ensure access to breakthroughs for all.
1
0
1
234
A milestone for biomarker-driven neoadjuvant immunotherapy! FDA approval of dostarlimab in dMMR rectal cancer points toward the ultimate goal: response-adapted therapy that may spare patients from surgery, chemo or radiation. #FinishCancer @providence. fda.gov/news-events/pr…
0
0
1
174
Delighted to welcome Prof. Andriy Morgun from @OregonState as our EACRI visiting professor to talk about his work on the microbiome and digital twins. Great talk and wonderful discussion. Looking forward to start of a productive collaboration to #FinishCancer @providence
0
0
3
185
Prognostic value of baseline modified barium swallow for perioperative dysphagia in oropharyngeal cancer: Secondary analysis of ECOG-ACRIN E3311
sciencedirect.com/science/articl…
sciencedirect.com/science/articl…
0
0
0
166
Pleased to see @providence included amongst @BeckersHR top health systems with a great oncology program. beckersoncology.com/oncology/100-h…
0
0
2
137
An incredible #EACMFS2026 meeting in Athens! Deeply grateful to Prof. Nicholas Kalavrezos @londonhead_neck for the honor of delivering the Presidential Lecture—and for his friendship & gracious hospitality. Inspired by colleagues from around the world advancing surgical care.
0
1
3
320
R. Bryan Bell, MD, DDS, FACS, FRCS(Ed) retweeted
Phil and Penny Knight have pledged $1.1 billion to create Oregon's first women's hospital and improve cardiac care. bizjournals.com/portland/news/…
0
2
5
674
R. Bryan Bell, MD, DDS, FACS, FRCS(Ed) retweeted
Phil and Penny Knight’s largest gift to Providence will create a new women’s hospital at St. Vincent and expand heart care.
9
11
81
7,782
What a great day to reach the #FinishCancer line- congratulations to all of the #HoodToCoast2026 particpants! A profound thank you to the 82 fundraising teams who collectively raised more than $1.16M in support of cancer research at @providence cancer institute! 🙏
0
0
6
151
At the #HoodToCoast exchange near downtown Portland & ran into the #CancerCrushers, an incredible team of @providence patients & caregivers, including the indomitable @roth_becky. Lots of people run this race who have survived cancer but few run it without fibulas-she’s fibulous!
0
0
5
201
To the @h2c Race Series team, Dan Floyd and especially to all of the runners, volunteers, donors, and supporters: thank you for going the distance for cancer research.
0
0
1
140
Race Day! #HoodToCoast, the mother of all relays is underway! Honored to be running in van #2 with the @providence #FinishCancer team, an amazing group of caregivers from our cancer institute and the Earle A. Chiles Research Institute. Go team!
0
0
0
140
FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer | FDA fda.gov/news-events/pr…
0
0
0
122
@moderna_tx , @Merck breakthrough could usher in a new era for cancer vaccines. Congrats to our own Dr. Matthew Taylor who led the trial @providence in Oregon and to all the investigators. #FinishCancer reuters.com/legal/litigati…
0
0
3
794
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial- congrats @BrendanCurtiMD & @providence team! ascopubs.org/doi/10.1200/JC…
0
0
2
458
The final paper from Gough/Crittenden Lab @providence is out in J of Immunology.
Kaede tracking shows the tumor-draining lymph node refills irradiated tumors with T cells — support for lymphatic-sparing immunoradiotherapy in H&N cancer. academic.oup.com/jimmunol/artic…
Kaede tracking shows the tumor-draining lymph node refills irradiated tumors with T cells — support for lymphatic-sparing immunoradiotherapy in H&N cancer. academic.oup.com/jimmunol/artic…
0
2
5
279
That's a wrap on @AHNSinfo 12th Int Meeting in Boston. The clear signal: perioperative immunotherapy has emerged as a new paradigm in head and neck oncology.
Honored to share the KEYNOTE-689 stage with @DrUppaluri, @RobertFerrisMD, @DrHaddadRobert & @TMWiseDraper. #AHNS2026
Honored to share the KEYNOTE-689 stage with @DrUppaluri, @RobertFerrisMD, @DrHaddadRobert & @TMWiseDraper. #AHNS2026
0
2
5
708
R. Bryan Bell, MD, DDS, FACS, FRCS(Ed) retweeted
Congratulations to Dr. Steven Rosenberg on this well-deserved honor recognizing his pioneering work in cancer immunotherapy. His discoveries have transformed cancer treatment and brought hope to patients worldwide. go.nih.gov/txIzeGl
4
19
100
7,707